And one study suggested that the occurrence of pulmonary edema in COVID-19 patients may be related to the radio-permeable TRPV4 channel, and the pulmonary edema caused by the virus can be alleviated by TRPV4 inhibitors [31]. The gene discussed is TRPV4; the disease is edema.